RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro
Francesco Acquati(University of Insubria), Roberto Taramelli(University of Insubria), Paola Campomenosi(University of Insubria), Paola Bonetti(Center for Pediatric Endocrinology Zurich), Annalisa Grimaldi(University of Insubria), Francesca Sanvito(Vita-Salute San Raffaele University), Cristina Riva(Ospedale di Circolo e Fondazione Macchi), Paolo Ghia(Vita-Salute San Raffaele University), Caterina Doglioni, S Bertilaccio(Lymphoma Research Foundation), Carlo Capella(University of Insubria), Laura Monti(Institute of Molecular Science and Technologies)
IrInSubria (University of Insubria)
January 1, 2009
Cited by 0
Related Papers
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890